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Mechanistic Modelling of DNA 
Repair and Cellular Survival 
Following Radiation-Induced DNA 
Damage
Stephen J. McMahon1,2, Jan Schuemann1, Harald Paganetti1 & Kevin M. Prise2
Characterising and predicting the effects of ionising radiation on cells remains challenging, with the 
lack of robust models of the underlying mechanism of radiation responses providing a significant 
limitation to the development of personalised radiotherapy. In this paper we present a mechanistic 
model of cellular response to radiation that incorporates the kinetics of different DNA repair processes, 
the spatial distribution of double strand breaks and the resulting probability and severity of misrepair. 
This model enables predictions to be made of a range of key biological endpoints (DNA repair kinetics, 
chromosome aberration and mutation formation, survival) across a range of cell types based on a set 
of 11 mechanistic fitting parameters that are common across all cells. Applying this model to cellular 
survival showed its capacity to stratify the radiosensitivity of cells based on aspects of their phenotype 
and experimental conditions such as cell cycle phase and plating delay (correlation between modelled 
and observed Mean Inactivation Doses R2 > 0.9). By explicitly incorporating underlying mechanistic 
factors, this model can integrate knowledge from a wide range of biological studies to provide robust 
predictions and may act as a foundation for future calculations of individualised radiosensitivity.
Following more than a century of investigations into the impact of ionizing radiation on biological systems, radi-
ation is one of the most well-studied genotoxic agents and a key cancer therapy. Much of our modern understand-
ing of genetics and cellular biology has been built, in part, on investigations of irradiated cells and tissues1. 
However, despite this wealth of knowledge, most clinical radiotherapy is still based on the application of the 
linear-quadratic model, defining survival, S, in terms of the dose D of radiation received and two empirical fitting 
parameters α and β: = α β− −S e D D
2
. Whilst it is widely acknowledged that this is only an approximation of the 
true behaviour of the system and considerable debate exists about its wider applicability2, this characterisation 
represents a useful surrogate for tumour control and normal tissue complication and broadly captures the sensi-
tivity of tumours at a population level. As a result, the linear-quadratic model remains a mainstay of clinical 
practice, for example in the calculation of biologically effective doses (BEDs) to compare the impact of different 
fractionation schedules3.
Population-level characterisations of radiosensitivity are necessarily limited, however, as highlighted by our 
growing knowledge of cancer’s underlying genetic hetreogeneity4. This heterogeneity is reflected in the varied 
radiation response of tumours–even among those arising in the same sites–as seen in in vitro experiments and 
clinical response5. The integration of genetic heterogeneity to provide personalised radiotherapy dose prescrip-
tions could significantly improve treatment outcomes and offer a more rationally informed balance between 
tumour control and normal tissue toxicity.
This seems particularly attractive given that many of the genetic determinants of radiation response are well 
understood–processes such as DNA repair and cell-cycle arrest have been extensively studied, both directly with 
radiation as well as in the wider field of molecular biology. However, the linear-quadratic model is poorly suited 
to understanding these factors, as its empirical parameters are only indirectly linked to the mechanistic drivers of 
radiation response, making it difficult to predict quantitatively the impact of a given mutation. This is particularly 
true when multiple genes are mutated, as occurs commonly in cancer.
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One approach to understand this heterogeneity is to use bioinformatics techniques to identify key genes or 
signatures to stratify patients into different sensitivity groups6,7. While promising, these approaches typically do 
not take advantage of our mechanistic understanding of radiation response, and so are often poorly conditioned 
and require extremely large data sets to generate robust, translatable signatures.
An alternative approach is to incorporate these factors into radiation response models. There has been con-
siderable interest in this area, including numerous analytic models which seek to more explicitly incorporate 
underlying mechanisms (such as the Lethal-Potentially Lethal lesion or the Repair-Misrepair models8,9), and the 
inclusion of additional parameters to reflect conditions such as dose rate (the Lea-Catcheside dose protraction 
factor), oxygen availability (Oxygen Enhancement Ratio), radiation quality (Relative Biological Effectiveness) 
and tissue geometry10–14. In addition, more detailed cell survival models have been developed which seek to more 
explicitly incorporate these effects in their underlying model structure15,16. Alongside this, numerous models 
have been developed of individual pathways such as DNA repair, chromosome aberration formation, apoptosis 
or intercellular signalling17–20.
However, these models are often limited to focus either on a single pathway or endpoint, and as such cannot 
incorporate the broad spectrum of response data within the radiation biology literature. In this work, we develop 
a model which implements high-level characterisations of DNA repair through different pathways, cell cycle 
effects, and cell death processes to provide a mechanistically defined model of cellular responses to ionising 
radiation. This model is based on a temporal and spatial model of DNA repair incorporating a Gaussian spatial 
dependence of Double Strand Break (DSB) misrejoining and varying fidelities of different repair processes. Based 
on this approach, the model is able to predict cellular responses for multiple endpoints for a range of experimental 
conditions and cells of different genetic backgrounds, based on a single set of parameters common to all cell lines 
rather than ad-hoc parameter sets for each cell line. This model provides a framework to incorporate mechanistic 
genetic knowledge into radiosensitivity predictions and to support the development of personalised radiotherapy 
models, and demonstrates an approach which may be applied to better understand other clinical techniques in 
the future.
Methods
Model Overview. This model initially focuses on DSB induction and repair following exposure to sparsely 
ionising X-ray radiation. Because of the low Linear Energy Transfer (LET) of such radiation, resulting DSBs are 
distributed randomly and uniformly throughout the nucleus. Developments to other radiation types may later 
draw on nanodosimetric models to generate more accurate spatial DSB distributions21.
Repair of these DSBs is modelled in a temporal fashion, taking into account the three key repair processes 
within cells–Nonhomologous End Joining (NHEJ), Homologous Recombination (HR), and Backup or 
Microhomology Mediated End Joining (MMEJ). As each break is repaired, it can either be repaired correctly 
(where the two free ends of a DSB rejoin correctly), or misrejoined, when ends from two distinct DSBs are com-
bined, leading to genetic alterations which can have physiological impacts on the cell. The rate of rejoining 
between any two free ends is taken to scale with the distance between them as ζ ∝ σ
−
d e( )
d2
2 2  where ζ is the rejoin-
ing rate, d is the separation between ends, and σ is a characteristic rejoining range. This rate applies to both 
‘correct’ ends (the pair created by a single DSB) as well as all mismatched pairs. Such an approach has been 
adopted by other researchers in the past to describe spatial effects in radiotherapy18,22. By considering both the 
total rate of rejoining and the spatial distribution of breaks, other factors can be calculated such as the rate of 
inter- and intra-chromosome events and the size of resulting deletions. These rates can then be used to generate 
predictions of various biological endpoints.
While such a model can readily be implemented in a stochastic Monte Carlo fashion, this is often time-consuming, 
particularly for rare endpoints, and so analytic solutions were derived for the rates of relevant processes. This 
analytic model is summarised below, with additional details on its implementation and validation presented in 
the Supplementary Information, along with a Python implementation.
DSB Induction and Repair Kinetics. X-ray induced DSBs have been extensively studied, with results sug-
gesting an initial yield of approximately 35 DSBs/Gy in human cells in the G1 phase of the cell cycle23. This value 
scales linearly with the DNA content of the nucleus, e.g. across species or between different phases of the cell 
cycle23. Assuming a human diploid cell contains 6.1 Gbp (Genome Reference Consortium, GRCh38.p6), this 
gives a rate of 5.738 DSBs/Gy/Gbp, which is taken as a constant.
These breaks are repaired by one of three processes. In normal cells, NHEJ can repair DSBs throughout the cell 
cycle, and HR becomes available in late S and G2 phases for higher-fidelity repair of complex damage using the 
replicated sister chromatid. Finally, in cells where NHEJ or HR is inhibited a fall-back process known as Backup 
or Microhomology-Mediated End Joining (MMEJ) is used, although this pathway is significantly slower and more 
error-prone24.
We model the repair of breaks by each process with independent exponential kinetics with characteristic rates. 
This gives rise to a three-phase behaviour for DNA repair, with breaks repaired either with fast kinetics (simple 
breaks, via NHEJ), slow kinetics (complex DSBs, repaired via HR when available and NHEJ if not) and very slow 
kinetics (breaks repaired via MMEJ due to HR or NHEJ failure). The overall behaviour is then:
= + +λ λ λ− − −N t N p e p e p e( ) ( ) (1)f
t
s
t
m
t
0
f s m
where N(t) is the total number of DSBs at time t, N0 is the initial number of DSBs, λx are the three repair rate 
constants (Fast, Slow, and Microhomology, respectively), and px is the probability of a break being repaired by 
each process.
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Rather than directly fitting pf, ps and pm for each cell line, these probabilities are calculated on a mechanistic 
basis based on two fitting parameters. Firstly, breaks are randomly selected to be either simple or complex based 
on a probability pc. This parameter is related to the quality of the incident radiation, and is taken as a single fitting 
parameter across all X-ray radiation types. Simple breaks are initially associated with fast repair kinetics, and 
complex breaks with slow repair kinetics (that is, pf = (1 − pc), ps = pc and pm = 0 in repair-competent cells).
Next, if a cell has a defect in the preferred repair pathway for a break, a portion of these breaks will fail to be 
efficiently repaired with probability pfail and will instead be repaired by MMEJ. For example, if a cell in G2 has a 
defect in NHEJ, the repair probabilities would become pf = (1 − pc)(1 − pfail), ps = pc and pm = (1 − pc)pfail. A full 
tabulation of this approach is presented in the Supplementary Information.
This approach gives a set of five fitting parameters (λf, λs, λm, pc, and pfail) which characterise the rates of repair 
as a function of time in cells under a range of experimental conditions and genetic backgrounds.
DSB Repair Fidelity. While DSB repair is a high fidelity process, there remains a significant risk of misrepair 
leading to mutations and genetic aberrations, which is known to be a spatially-dependent process18,22. By model-
ling the behaviour of breaks using the Gaussian rejoining probability outlined above, the fraction of misrepaired 
breaks can be calculated as a function of the initial number of breaks, N0, and σ. For breaks distributed uniformly 
within a spherical nucleus, it can be shown (see Supporting Information) that the probability of a DSB correctly 
rejoining is given by
η σ
=
− η σ−P e
N R
1
( , , ) (2)Correct
N R( , , )
0
0
where η is the effective integral misrejoining probability for a single randomly placed DSB within a nucleus of 
radius R with rejoining range σ when there are initially N0 other DSBs present within the system. This rejoining 
rate can be exactly calculated as:
η σ
pi
θ σ ω σ=N R N
R
R R( , , ) 6
4
( , ) ( , )
(3)0
0
3
where the first term is the density of free DSB ends within the nucleus, θ is the rejoining rate between two ran-
domly placed DSB ends, and ω is a correction coefficient to account for skew in the η distribution for very small 
σ. These can be calculated as:
θ σ piσ pi σ
σ
σ σ σ σ=



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


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− − + −
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ω σ = + −
σ−R A A e( , ) (1 ) (5)
B
R
where A and B are geometric fitting parameters, with values 0.757 and 5.39 respectively, determined by matching 
this function to the output of a Monte Carlo simulation of break rejoining, as illustrated in the Supplementary 
Information.
One additional factor in DNA repair is that different processes have different inherent fidelities, even in the 
absence of misrejoining with other breaks. To reflect this, we associate a base fidelity with NHEJ and MMEJ, such 
that the probability of correct repair is given by
µ
η σ
=



− 


η σ−
P e
N R
1
( , , ) (6)
Correct x
N R( , , )
0
0
where μx is a process-specific fidelity. For homologous recombination, it is assumed that repair always completes 
successfully, giving PCorrect = 1.
While this provides total misrejoining rates, the severity of these events is governed by the location of the 
involved DNA ends, and can range from a short deletion to aberrant bridges between chromosomes. Quantifying 
the rates of these different events is an important factor in modelling the effects of ionizing radiation on DNA25.
Chromosome Aberrations–G1. Chromosome aberrations are large-scale genomic rearrangements 
between and within chromosomes leading to the deletion of DNA or the formation of aberrant chromosomes 
(rings, dicentrics) that are unable to segregate properly during mitosis. These events can have a high probability 
of lethality and are one of the most biologically significant effects of ionising radiation.
Aberrations can be classified as inter- or intra- chromosome, depending on which chromosomes provided the 
damaged free ends. As a highly simplified model of chromosome structure, chromosomes are modelled as spher-
ical sub-volumes with radius =rc
R
nc3
, where nc is the number of chromosomes within the nucleus. This 
approach neglects variations in chromosome size, shape and packing that would be expected to impact the type 
and distribution of aberrations. However, as this analysis focuses on average rates across the whole nucleus, the 
impact of these factors is significantly reduced. When misrepair occurs, the probability of an intra-chromosome 
event is given by the ratio of the rate of rejoining within the chromosome to that across the whole nucleus, given 
by:
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θ σ
θ σ
=P r
R
( , )
( , ) (7)intra
c
A second important classification is whether the exchange is symmetric or asymmetric. In a symmetric 
exchange, all chromosomes contain exactly one centromere, while asymmetric exchanges form acentric frag-
ments, dicentrics and other complex rearrangements25. Symmetric exchanges are typically non-lethal, while 
asymmetric events are often incompatible with cell survival.
The symmetry of an exchange is solely determined by whether the DNA ends which rejoin are correctly 
aligned (i.e. centromere-containing fragment to centromere-free fragment) or not. As the DNA ends are other-
wise identical, symmetric and asymmetric exchanges are taken to occur with equal frequency, that is Pasym = 0.5.
Based on these assumptions, the total number of misrepaired DSBs, and corresponding number of dicentrics 
(asymmetric inter-chromosome) and deletions (asymmetric intra-chromosome) can be calculated as:
= − −
= . −
= .
N t N N t P
N N P
N N P
( ) ( ( ))(1 )
0 5 (1 )
0 5 (8)
mis Correct
dic mis ra
del mis ra
0
int
int
where Nmis(t) is the number of misrepaired DSBs at time t, and the factor 0.5 represents the probability of an 
asymmetric exchange. Because of the time dependence of this term, formation of dicentrics and deletions is also 
a time-dependent process, however for brevity this is excluded from subsequent expressions. For the purposes 
of this analytic formulation, all acute exposures are considered as happening instantly, meaning all N0 DSBs are 
created instantly before any repair. More complex patterns incorporating intra-exposure repair can potentially be 
calculated using Monte Carlo techniques.
For deletions, size is also an important factor. Based on the assumption that the separation of two breaks in 
base pairs along the chromosome increases monotonically with spatial distance between the free ends, the size of 
a deletion in base pairs is =D Lr
R
2 D
3
3 , where L is the total length of all chromosomes (in Gbp) and rD the separation 
between ends forming the deletion.
The rate of deletions smaller than D is given by the rate of misrejoining events over distances shorter than rD, 
assuming both events occur within the same chromosome. This is given by
θ σ
θ σ
=<P
r r
r
( , , )
( , ) (9)del D
c D
c
where the generalised form of θ is:
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As the visibility and lethality of lesions often requires them to be above a certain size, the number of deletions 
larger than D can be expressed as:
= . −> <N N P P0 5 (1 ) (11)del D mis intra del D
Mutation Rates. In addition to lethal aberrations, radiation can induce non-lethal mutations where genes are 
deleted or altered, leading to changes in cellular function. Mutations are typically assayed on single genes whose 
alteration has significant impacts on cell survival in a particular condition–such as the Hypoxanthine-guanine 
phosphoribosyl-transferase (Hprt) gene26. These mutations are typically rare events, and are dependent on the 
size of the gene under consideration.
Misrepair events can cause mutation in two ways–either partial alterations (breaks within the gene misrejoining) 
or total deletions (two breaks outside a gene misrepairing to create a deletion which spans the gene).
The number of total deletions for a gene of length g can be calculated as:
∫= − > +N L N db
1
2 (12)mutTotal b del b g
0
( )
max
where for each point at a distance b base pairs before the start of the gene, the probability of a deletion event 
occurring which spans the whole gene in consideration is calculated, ranging from the start of the gene (b = 0) to 
bmax, the largest deletion which is compatible with cell survival. This is normalised according to the total length 
of the genome, L.
For intra-gene events, the rate can be calculated by assuming that all misrepair events involving a break within 
the gene are taken to lead to mutations, given by:
=N N g
L (13)mutPartial mis
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In addition to misrepair events, even joining of the correct DSB ends may lead to short point mutations in a gene 
due to imperfect repair leading to small insertions or deletions. To reflect this, a point mutation factor, ν, is intro-
duced, with the number of point mutations given by:
ν= −N N N g
L
( ) (14)mutPoint mis
Chromosome Aberrations–G2. In G1, inter-arm exchanges (intra-chromosome events which span the 
centromere) do not have increased visibility compared to other intra-chromosome events. However, in G2 these 
events have a much higher visibility due to the structural changes involving the sister chromatid. The rate of 
inter-arm aberrations can be estimated by considering the rate at which an aberration spans some or all of the 
centromere, in a similar way to the deletion of a single gene, above. Thus the inter-arm aberration rate is similarly 
given by:
∫= − . >N
N l
L
P db
(15)interArm
mis c
l
del b
0 5
0
c
where the centromere is assumed to have negligible size (i.e. g = 0). The integral is carried out over the whole 
average chromosome length lc, as chromosome aberration assays typically do not require the long-term survival 
of the cell.
DNA Repair Model Implementation and Fitting. This model has been implemented in Python for a 
general cell, based on two sets of input values. The first is the set of nine mechanistic fitting parameters-λF, λS, λM, 
pc, pfail, σ, μNHEJ, μMMEJ and ν, which are the same across all cell lines. The second set are those specific to a given 
experiment. These include details of the phenotype of the cells being investigated (its genome size and chromo-
some number, and any defects in DNA repair processes) and experiment-specific parameters (the dose delivered, 
the phase the cells were in during irradiation, and the time after irradiation when the endpoint was measured).
Cell-specific values (such as the initial number of DSBs and the proportions of repair by different processes, 
pf, ps and pm) are then determined by combining these experimental and mechanistic parameters. From these, 
observable endpoints such as residual DSBs, numbers of visible and lethal chromosome aberrations, and rates of 
mutation can be calculated.
To fit these model predictions, a number of data sets were obtained from the literature, including measure-
ments of DNA repair through γ H2AX fluorescence27,28, DNA misrepair rates using PFGE29,30, chromosome aber-
ration yields18,31–37 and mutation rates38–40. Values were extracted from published tables or figures along with 
associated uncertainties. To reflect uncertainties in data extraction and experimental methods, an additional 5% 
random uncertainty was added to all points. A single simultaneous fit was carried out across all data varying the 
9 fitting parameters. By simultaneously fitting to a wide range of endpoints, the model generates a robust, unique 
parameter set, with reasonable uncertainties and small covariances. This fit was carried out in Python using the 
SciPy curve_fit routine, using a weighted nonlinear least squares algorithm. The resulting best-fit parameters are 
presented in Table 1, and these values were used to calculate all of the curves presented below. The model imple-
mentation, fitting algorithm, and input data sets are presented in the Supplementary Information, together with 
the characteristics of cell lines analysed as part of this work.
A number of additional endpoints (yields of sub-types of chromosome aberrations, low dose rate chromo-
some aberration yields and point mutation rates) were extracted, but not incorporated in the fit, to test underlying 
model assumptions.
Parameter Meaning Value
DNA Model Parameters
DNA Damage Yield 5.738 DSB/Gy/Gbp
λF Fast Repair Coefficient 3.6 ± 0.6 hours−1
λS Slow Repair Coefficient 0.15 ± 0.02 hours−1
λM MMEJ Repair Coefficient 0.0084 ± 0.0015 hours−1
pc Complex break probability 0.42 ± 0.03
pf Repair Failure Probability 0.67 ± 0.09
σ Misrejoin range 0.0428 ± 0.0005 Rnuc
μNHEJ NHEJ Fidelity 0.985 ± 0.002
μMMEJ MMEJ Fidelity 0.465 ± 0.05
ν Point Mutation Rate 0.044 ± 0.005
Survival Model Parameters
ψ Mitosis Sensitivity 0.014 ± 0.002 break−1
ϕ Apoptosis Sensitivity 0.0085 ± 0.001 break−1
Table 1.  List of fitting parameters used in this work, and best fit parameter values from model. 
DNA damage yield is taken as a fixed value from the literature, while other values are presented as best fit 
parameters ± one standard deviation fitting uncertainty.
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Survival. Cell survival is one of the key biological endpoints of radiation exposure. In the simplest case, the 
response of non-cycling cells (e.g. those arrested in G1/G0) is driven by the formation of lethal chromosome 
aberrations–that is, those which prevent chromosome segregation at mitosis (dicentrics, rings) or those which 
disrupt cellular function through the loss of genetic material (large deletions). Such effects have been shown to 
correlate well with Giemsa-stained aberration counts, which are sensitive to deletions greater than 3 Mbp in size41.
For non-cycling cells G1 survival can thus be calculated as = − − >S e N Ndic del MBP3  (assuming Poisson-distributed 
aberrations, a reasonable approximation for X-rays). For cells irradiated in G2, the replicated chromatids mean 
that either both must see large deletions, or the aberration must be sufficient to prevent successful mitosis. As a 
result, the survival rate is estimated as = − −S e N Ndic erArmint . This neglects the case where cells see multiple lethal 
deletions across chromatids passed down to both daughter cells, but this is relatively rare at clinical doses.
Two other effects are significant in cycling cells–mitotic death and radiation-induced arrest. Mitotic death is 
triggered when cells undergo mitosis with unrepaired DSBs–either due to newly formed breaks42, or escaping the 
G2 DNA damage checkpoint (which is known to occur when fewer than 20 DSBs remain43). The exact mecha-
nisms of mitotic death are not fully understood, but experimental evidence44 indicates that these cells die with 
approximately exponential kinetics in dose, with similar rates across cell lines. Thus, the probability of surviving 
mitosis is modelled as a single exponential, = ϕ−S emitosis
N m, where Nm is the number of DSBs present in mitosis 
and ϕ is a rate constant shared across all cells.
Radiation-induced arrests are complex processes, and are triggered by a range of factors. While they are 
induced throughout the cell cycle in response to initial damage, they are typically transient once DNA repair is 
completed. However, they have an important impact on in vitro survival in G1, where arrest can be followed by 
long-term senescence or apoptosis. Quantification of the relative contribution of apoptosis and senescence to 
survival remains challenging45, and even a partial model of these processes is outside the scope of this work. 
Consequently, a highly simplified model of G1 arrest and apoptosis is considered here. Cells which are cycling 
and have a functional G1 arrest have a probability of successfully escaping G1 of = ψ−S eapop
N G1, where NG1 is the 
number of DSBs induced in G1 and ψ is again common across all cells. While simple, this is broadly in line with 
observed kinetics of escape from G1 for irradiated cells46. For cells that are not sensitive to these processes (those 
not cycling, in different phases, or with a mutation in a gene essential to this process such as p53) this event is not 
triggered.
As for the DNA repair model, survival data was extracted from the literature to validate the model for a range 
of hamster and human cell lines, different cell cycle phases, different genetic backgrounds and experimental 
conditions23,27,41,47–51. To characterise ϕ and ψ, a limited fit was carried out to these survival data, taking parame-
ters from the DNA model as fixed inputs to reduce the impact of the relatively low reproducibility of clonogenic 
survival data.
Results
DNA Repair Kinetics. Measurements of DNA repair using γ H2AX foci were obtained for mouse and human 
cell lines with a range of repair defects, irradiated in G1 and G227,28. These papers were selected as they repre-
sent systematic studies of cell lines with similar origins (human or mouse fibroblasts) with known mutations in 
individual genes in key DNA repair pathways. It is important to note that there is significant inter-laboratory 
variability in γ H2AX foci counts, even for nominally identical experiments. However, within a single site, relative 
foci yields are consistent52. As a result, for each paper under consideration a single scaling factor was applied 
across all reported foci counts, to account for variations in staining and counting procedures between groups by 
normalising each set of results to the model’s predicted total yield of DSBs. These scaling factors were 1.70 and 
1.02 for Kühne et al.27 and Beucher et al.28, respectively. In addition, observation times were offset by 7.5 minutes 
to account for the known lag between DSB creation and foci appearance53.
The model’s predictions for these cells are compared to experimental observations in Fig. 1, normalised to the 
initial number of foci predicted at t  = 0. It can be seen that at time-points ranging from 15 minutes to 300 hours, 
the model agrees well with the overall rates of repair in different phases of the cell cycle for both human and 
mouse cell lines. As these lines also represent different repair defects, this also enables the determination of 
unique rate constants for each of the classes of DNA repair, the rate at which complex damage is formed, and the 
probability of repair failure in DNA repair defective cells.
While such a multi-exponential approach is well established in the analysis of DNA repair kinetics, by com-
bining it with the misrepair models it can provide key constraints on parameters (such as the rate of repair failure 
in different mutant cell lines) which cannot be directly assessed from misrepair measurements alone. Thus, by 
combining these different experimental data points, better links can be drawn between fundamental mechanisms.
Misrepair. Although almost all DSBs are repaired after long time periods, the fidelity of this repair is not guar-
anteed, and misrepair is one of the key drivers of radiation-induced cell killing. Pulsed Field Gel Electrophoresis 
measurements of the correct rejoining of particular sections of DNA have been obtained to assess the overall rate 
of misrepair in irradiated cells29,30 and converted to misrepair rates per DSB. These observations were compared 
to the model’s predicted rates of misrejoining as a function of dose, as illustrated in Fig. 2, showing good agree-
ment at doses from 5 to 80 Gy, although the uncertainties on many measured points are considerable. This corre-
lation indicates that the overall misrepair model is reasonable, scales well at higher doses, and provides parameter 
constraints for applications to clinically relevant endpoints at lower doses.
Chromosome Aberrations. There are a number of different techniques to quantify chromosome aber-
rations, including techniques such as Giemsa staining of chromosomes at mitosis, or Fluorescence In Situ 
Hybridisation (FISH) which can be used to stain specific chromosomes, or in the case of M-FISH54 to uniquely 
www.nature.com/scientificreports/
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Figure 1. Comparison of modelled DNA repair curves (lines) and experimental data (points) for DNA 
repair, derived from γH2AX foci measurements. Models were applied to human or mouse cell lines, either 
with competent repair (solid line) or defective repair (NHEJ defective: dashed line; HR defective: dotted line, 
not visible in G1). Responses were modelled for G1 (left) and G2 (right), for short and long times (top, bottom 
respectively). Point types represent different cell lines and defects, and are coloured according to source 
publication (green Beucher et al.28, blue Kühne et al.27). Mutations represented are: 1: XLF mutant, 2: DNA 
Lig-IV mutant; 3: BRCA2 mutant; 4: Rad54 mutant.
Figure 2. Comparison of modelled rate of misrepair to measurements of incorrectly rejoined DNA 
fragments via PFGE in normal human cells (From Löbrich et al., Rydberg et al.29,30). Although uncertainties 
in these measurements are large, good correlation is seen over a wide range of doses.
www.nature.com/scientificreports/
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stain chromosomes or chromosome sub-regions. These techniques have different resolutions and are able to dis-
tinguish different events (for example, symmetric exchanges are frequently not visible under Giemsa staining), 
making it difficult to make direct comparisons between the results of different studies.
In this work, total numbers of chromosome aberrations as a function of dose were obtained from the litera-
ture for cells irradiated in G1 and Giemsa-stained at first mitosis18,31–37. This assay is sensitive to the formation 
of dicentrics, large deletions, and rings, and so these observations were compared to model predictions for total 
yields of dicentrics (Ndic) and large deletions (Ndel>3Mbp), as plotted in Fig. 3a. Although there is considerable 
inter-experimental variation between studies, the overall trend is well reflected across the range of doses consid-
ered here. In addition, good correlation is seen for cells with a NHEJ defect, and in human-hamster hybrid cells 
with a differing genome size and chromosome number.
A similar approach can be applied in the G2 phase of the cell cycle, to aberrations measured through the 
use of premature chromatin condensation (PCC)32. As this technique can measure aberration yields at specific 
time-points, the kinetics of aberration formation can be quantified. In G2, in addition to the inter-chromosome 
and large deletion events visible in G1, inter-arm events (Ninterarm) are also visible, due to the presence of the sister 
chromatid. Figure 3b compares the observations and model predictions as a function of time. Good agreement 
can be seen, demonstrating the link between DNA repair kinetics and misrepair, as well as the incorporation of 
the increased visibility of aberrations in G2 and the increased fidelity of repair by homologous recombination.
While model parameters were determined based on the total yield of aberrations following acute radiation 
exposures, some other endpoints have also been considered to test model assumptions. Specifically, the relative 
yield of different aberration types (dicentrics vs deletions) and the yield of aberrations at very low dose rates were 
Figure 3. Comparison of experimental measurements and model predictions of chromosome aberrations 
produced per cell. (a) Comparison of overall aberration rates as a function of dose in normal human cells 
(circles, solid line), hamster-human hybrid cells (diamond, dotted line) and human cells with defective NHEJ 
(triangles, dashed line), measured through Giemsa staining of cells irradiated in G118,22,31,33,34,36,37. Points are 
coloured according to source publication. Good agreement is seen across a range of clinically relevant doses, 
although there is significant inter-experimental heterogeneity between different reports. (b) Comparison of 
aberration yields as a function of time for different doses delivered to cells in G2, assessed through premature 
chromosome condensation in normal human fibroblasts32. The two bottom panels present data not included 
in overall fitting, analysed to assess model robustness. (c) Comparison of yields of dicentrics (dashed line) and 
total aberrations (solid line) from Cornforth et al.37. Although dicentrics data was not included in the fit, their 
proportion is still accurately predicted. (d) Induction of chromosome aberrations of different classes exposed 
at an extremely low dose rate (< 10 cGy/h)37, where intra-chromosome recombination is negligible. While only 
acute exposures were included in fitting parameter set, once again good agreement is seen.
www.nature.com/scientificreports/
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compared to model predictions, without being included in the model fitting data. As can be seen in Fig. 3c,d, the 
model broadly reproduces the total yield of dicentrics as a function of total aberrations, both for acute exposures 
(3c) and exposures at extremely low dose rates (3d, dose rate < 0.1 Gy h−1) where multiple-DSB interactions are 
extremely rare. For the low dose-rate analysis, this is achieved by setting η = 0 when calculating repair kinetics, 
preventing any misrepair resulting from multiple DSBs rejoining.
These results indicate that the simple model of non-overlapping chromosomes applied here does not dramat-
ically impact on the model’s applicability when considering whole-cell rates of genetic aberrations, and that its 
predicted estimates for the base fidelities of DNA repair are also reasonable.
Mutations. Measurements of the rate of induction of mutation in the Hprt gene in Chinese Hamster cells 
were obtained from the literature38–40 and compared to model predictions, as illustrated in Fig. 4. As in the 
chromosome aberration analysis, these comparisons were made both for the total rate of mutations, which was 
included in the fitting data set, as well as for the rate of point mutations which was excluded from the fitting data. 
Good agreement is seen, indicating that the DNA repair model is also applicable to considering the impact of 
misrepair on specific genetic sub-regions.
Survival. As described above, by considering an exponential dependence between aberration yield and cell 
survival, predictions of survival can be generated from the DNA repair model for non-cycling cells. These pre-
dictions were compared to data from a series of hamster and human cell lines23,27,41,47–51, selected for irradiations 
in conditions where there was little sensitivity to cycling effects. For human fibroblast cells, this includes cells 
irradiated and held in G1 for more than 24 hours before being plated for survival quantification. CHO cells were 
irradiated in G1, but have a defective G1 checkpoint55 and so were not prevented from entering S phase and do 
not undergo long-term arrest or apoptosis at the G1/S checkpoint. Comparison of model predictions and exper-
imental observations are shown for these cells in Fig. 5a,c. Despite no additional fitting parameters being used, 
the mechanistic DNA model produces accurate predictions of radiation sensitivity for both repair-competent and 
NHEJ-defective cells (solid and dashed lines respectively).
In cycling cells, two main additional pathways contribute to cell death–mitotic catastrophe, and active cell 
cycle arrest followed by senescence or apoptosis. As described above, both of these have been incorporated in the 
current approach as a simple exponential death process in the current model based on initial yields of DSBs, with 
the fit parameters (ϕ and ψ) presented in Table 1.
Data for cells irradiated in mitosis was taken from a series of papers44,56,57 and is shown in Fig. 6, while CHO 
cells irradiated in G2 and human fibroblasts irradiated while cycling in G1 are shown in Fig. 5b,d. Overall trends 
are well described in all cases, reflecting numerous well-known aspects of radiation response, such as the greater 
sensitivity of cycling cells to radiation, and the increased radiation resistance of NHEJ defective cells irradiated 
in G2. Significant inter-experiment variation persists however, even on similar endpoints, because of differences 
in mutant populations, varying cell cycle selections, plating techniques, and other subtly different experimental 
conditions which are not currently explicitly incorporated in this model (e.g. in Fig. 5, one CHO cell line shows 
survival an order of magnitude lower at high doses, perhaps due to the use of serum starvation to synchronise 
these cells). This suggests that it is important not to over-fit to a particular set of experimental observations.
Despite this, the model still reproduces the behaviour of cell lines well across a range of conditions with-
out cell-line specific fitting parameters. To quantify the model’s ability to stratify radiation sensitivity, Mean 
Inactivation Doses (MID) were calculated for each data set and for the corresponding model prediction, and 
compared in Fig. 7. The model effectively stratifies the sensitivity of different cell lines, with a high correlation 
coefficient (R2 = 0.91; 0.96 if divergent CHO line is excluded). In most cases the model slightly over-estimates the 
MID, suggesting that some death pathways are not yet fully accounted for. Thus while exact quantification of, for 
Figure 4. Comparison of modelled yields of mutation in the HPRT gene for Chinese Hamster cells 
irradiated in G1 (circles, solid line)38–40, and the fraction of point mutations (triangles, dashed line)40. 
Points are coloured according to source publication. Overall yield of significant gene damage is accurately 
reflected, as is the yield of small point mutations, which was not included in fitting data set.
www.nature.com/scientificreports/
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example, α/β ratios may prove challenging for a specific experimental condition, the model still has the potential 
to make useful predictions about overall sensitivity.
Discussion
A primary driver in modern medicine is the movement towards treatment personalisation for a patient’s unique 
disease, to derive maximum clinical benefit from new or established techniques. While radiotherapy has long 
been personalised based on geometric factors, tailoring of treatment dose and fractionation remains in its infancy. 
A key limiting factor is the lack of models with which to predict the sensitivity of an individual’s cancer. This is a 
particularly pressing need as our understanding of key pathways in radiation response has improved significantly 
in recent years, supported by molecular and cellular biology experiments as well as improved models of key path-
ways, offering a wealth of information which could be incorporated into clinical decision-making.
We have developed a general framework of cellular radiation response characterised using cellular phenotypic 
characteristics that can produce predictions of a range of endpoints including DNA repair, genetic aberration, and 
cellular survival. While other models have sought to make use of similar mechanistic approaches to radiation res
ponse16–18,35,58,59, we believe this is the first such model to explicitly incorporate this range of underlying mecha-
nistic processes and endpoints together with cell survival in a single model.
This approach has several benefits. Firstly, by developing a single model which incorporates a range of 
endpoints, data from different experiments can be combined to inform and constrain model parameters in a 
way which is not possible when considering empirical fitting functions. For example, this can be seen in the 
Figure 5. Comparison of modelled cell survival and experimental measurements for cells of different 
genetic backgrounds in different conditions. (a) Survival in Chinese Hamster cells irradiated in G1, either 
repair competent (CHO-K1, circles) or with defective NHEJ (triangles, diamonds). Curves are plotted for two 
modelled cell lines, either CHO cells irradiated in G1 with fully competent repair (solid line) or with defective 
NHEJ (dashed line). (b) Survival in CHO cells irradiated in G2, again either repair competent or with defective 
NHEJ (points as in top left), compared to model predictions (lines). (c) Survival in human fibroblast lines 
irradiated in G1, and held in G1 for over 24 hours before plating for survival assay to prevent G1 cell cycle arrest 
and apoptosis. (d) Survival in human fibroblast lines irradiated in G1 and immediately plated for survival. 
In lower panels, both normal (AGO-1522, MRC-5; circles) and NHEJ defective (180BR, 411BR; triangles, 
diamonds) lines are considered, compared to model predictions for either normal (solid line) or NHEJ defective 
(dashed line) cells, under similar plating conditions. Points are coloured according to source publication. 
Good agreement is obtained in panels on the left solely from the DNA repair model, as no parameters from the 
survival fit are needed to predict responses in these conditions. Panels on the right incorporate mitotic death 
and apoptosis, as described in the main text, to explain these additional conditions. Human data from27,37,49,50, 
hamster data from23,47,48,51.
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combination of H2AX kinetic and aberration data to characterise how repair processes fail, or the use of a single 
model to describe both mutation and aberration formation using a single set of fitting parameters, without the 
need to introduce an empirical scaling factor linking them. Thus while the model incorporates 11 parameters–9 
characterising DNA repair, and 2 cell death rates-the fit was carried out across nearly 200 experimental meas-
urements across multiple endpoints, numerous cellular phenotypes, and varying experimental conditions. As 
a result, the optimum parameter set is very stable and reproducible, with small confidence intervals on most 
parameters and a limited covariance between parameters (see Supplementary Information). Future developments 
which make use of additional mechanistic measurements (such as rates of senescence or apoptosis) may enable a 
further refinement of these parameters.
Another benefit is that in addition to the endpoints explicitly fit here, many established aspects of radiation 
biology emerge from this model. For example, while the majority of experiments analysed in this work con-
sider single fraction high dose-rate exposures, the model can be naturally extended to prolonged exposures or 
multi-fraction treatments by incorporating the induction of DSBs in a time-dependent manner, applying the 
same rules as used in the acute exposure case. Additionally, the current model focuses on X-ray exposures which 
are assumed to induce DSBs uniformly and randomly throughout the cell nucleus, neglecting any dependence 
on the linear energy transfer (LET). While this is a reasonable approximation, there is known to be some var-
iation in biological effectiveness for X-rays. Higher LET radiations such as protons or heavier ions can diverge 
Figure 6. Comparison of modelled cell survival and experimental observation for cells irradiated in 
mitosis. Symbols correspond to different cell lines, and are coloured according to source publication. For these 
highly-sensitive cells, death is dominated by mitotic catastrophe following unrepaired DSBs generated during 
mitosis. Data from44,56,57.
Figure 7. Stratification of cell sensitivity by model predictions, for mean inactivation dose (MID, points), 
compared to equality (solid line). Cells with identical genetic backgrounds and exposure conditions have 
equal model MIDs (X-axis), but a sometimes large spread in observed MID (Y-axis). However, despite this the 
model effectively stratifies across a broad range of radiation sensitivities, within experimental variation between 
reports on similar cell lines. Model cells tend to be more radiation-resistant than experimental observations 
(best-fit slope 0.91) which suggests some modes of cell death remain unaccounted for. However, the overall 
correlation remains high (R2 = 0.96), indicating good predictive power.
www.nature.com/scientificreports/
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significantly from this approximation, inducing heterogeneously distributed DSBs with differing dose depend-
ence. Incorporation of models to provide radiation-quality dependent DSB information may provide additional 
insights and the possibility of extending the model to applications such as the calculation of RBE15,21.
However, significant developments are required before this model can be applied in a general clinical setting. 
As the model currently focuses on in vitro responses, factors such as cellular heterogeneity and oxygen availability 
are not incorporated, despite being known to significantly impact clinical radiation responses. One approach to 
address this limitation would be the integration of the model into a 3D agent-based system60,61. In this approach 
individual cells are simulated within a three-dimensional tumour volume, which enables the incorporation of 
both cellular heterogeneity as well as spatially dependent variables such as oxygenation level in a spatially realistic 
tumour model.
The delivery of personalised radiotherapy will also depend on the development of more refined models of 
the genetic drivers of radiation response processes. In the current work much of the detail of underlying genetic 
mechanisms is not considered, with a single model applied across all species and pathways treated either as 
fully functional or fully defective. In reality, cellular processes depend in a complex fashion on a range of inter-
connected genes, all of which can have different impacts and may differ across species. The differential impact 
of genes can be seen in the small differences in sensitivity between xrs6 and V3 cells in Fig. 5. While both cells 
are treated as identically NHEJ defective, in reality their mutations (in Ku80 and DNA-PKcs respectively) have 
slightly different impacts on DNA repair or radiosensitivity.
While the current approach is sufficient to demonstrate the viability of the model, explicitly incorporating 
models of the underlying genetic pathways driving these effects will enable more granular models of the impact 
of tumour genetics. In this way, rather than population-level models of pathway failure, quantitative estimation 
of the degree of disruption can be generated for an individual tumour’s genetic information, rather than simply 
classifying a cell as, for example, NHEJ defective or competent.
By applying this approach to a tumour’s genetic information across all pathways involved in radiation 
response, an individualised model of the availability of these processes can be generated (e.g. individual values 
of pf, ps and pm), which can be combined with the mechanistic parameters obtained in this work to provide 
personalised predictions of radiosensitivity. As the acquisition of tumour genotypes is becoming increasingly 
affordable and part of the standard of care for many patients, this offers a natural complement to the growing 
personalisation in other aspects of cancer therapy. If clinically validated this approach may also be extensible to 
other clinical applications, beginning with other genotoxic agents (e.g. cisplatin, doxorubicin) whose effects are 
driven primarily by DNA damage, but also potentially to other agents whose fundamental mechanisms of action 
are sufficiently well known.
In conclusion, we have developed a mechanistic model of radiation response incorporating a range of key 
radiation response pathways and clinically relevant endpoints. This model has been shown to accurately describe 
responses for a range of scales and endpoints with a set of mechanistic fitting parameters which are common 
across all cell lines, enabling the integration of knowledge from a range of experimental measurements. This 
model has the potential to offer a foundation for the development of a novel tool to deliver individualised predic-
tions of radiosensitivity in the future.
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